| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |